Trial Profile
A pilot study to evaluate safety and efficacy of TNF alpha inhibitors in the treatment of patients with Hidradenitis Suppurativa
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
- 29 Mar 2016 New trial record
- 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology